| Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update |
46 |
| Impact of sodium glucose cotransporter 2 inhibitor on histological features and glucose metabolism of non-alcoholic fatty liver disease complicated by diabetes mellitus |
26 |
| Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis |
24 |
| Immune checkpoint blockade for the treatment of human hepatocellular carcinoma |
20 |
| Effect of luseogliflozin on hepatic fat content in type 2 diabetes patients with non-alcoholic fatty liver disease: A prospective, single-arm trial (LEAD trial) |
18 |
| Recent advances in medical management of hepatocellular carcinoma |
17 |
| Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real-world cohort study |
17 |
| Phase 3 drug pipelines in the treatment of non-alcoholic steatohepatitis |
17 |
| Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis |
16 |
| Clinical outcomes of sorafenib treatment failure for advanced hepatocellular carcinoma and candidates for regorafenib treatment in real-world practice |
16 |
| Randomized prospective study showing the non-inferiority of tenofovir to entecavir in treatment-naive chronic hepatitis B patients |
15 |
| Clinical characteristics and outcomes of candidates for second-line therapy, including regorafenib and ramucirumab, for advanced hepatocellular carcinoma after sorafenib treatment |
15 |
| Novel approaches for molecular targeted therapy against hepatocellular carcinoma |
13 |
| Prognostic impact of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation in patients with unresectable hepatocellular carcinoma: Comparison with TACE alone using decision-tree analysis after propensity score matching |
12 |
| Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study |
12 |
| Circulating microRNA-1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinoma |
12 |
| Entecavir treatment of hepatitis B virus-infected patients with severe renal impairment and those on hemodialysis |
11 |
| Differential expression of circular RNAs in hepatic tissue in a model of liver fibrosis and functional analysis of their target genes |
11 |
| Analysis of the liver functional reserve of patients with advanced hepatocellular carcinoma undergoing sorafenib treatment: Prospects for regorafenib therapy |
11 |
| Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts early occurrence of hepatocellular carcinoma after sustained virologic response by direct-acting antivirals for hepatitis C virus |
10 |
| Effect of tolvaptan on the prognosis of patients with hepatic ascites |
10 |
| Interleukin-10 secreted by mesenchymal stem cells attenuates acute liver failure through inhibiting pyroptosis |
10 |
| Remaining hepatocellular carcinoma risk in chronic hepatitis B patients receiving entecavir/tenofovir in South Korea |
10 |
| Slow walking speed overlapped with low handgrip strength in chronic liver disease patients with hepatocellular carcinoma |
10 |
| Non-invasive liver fibrosis assessment correlates with collagen and elastic fiber quantity in patients with hepatitis C virus infection |
9 |
| Hepatitis B virus (HBV)-infected patients with low hepatitis B surface antigen and high hepatitis B core-related antigen titers have a high risk of HBV-related hepatocellular carcinoma |
9 |
| Changes in liver function and body composition by direct-acting antiviral therapy for hepatitis C virus infection |
9 |
| Predictors of hepatocellular carcinoma occurrence after direct-acting antiviral therapy in patients with hepatitis C virus infection |
9 |
| High recovery rate of consciousness by high-volume filtrate hemodiafiltration for fulminant hepatitis |
9 |
| Skeletal muscle volume loss during transarterial chemoembolization predicts poor prognosis in patients with hepatocellular carcinoma |
9 |
| Incidence and risk factors of hepatocellular carcinoma change over time in patients with hepatitis C virus infection who achieved sustained virologic response |
9 |
| Increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan |
9 |
| Real-world efficacy and safety of sofosbuvir plus ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group |
8 |
| Countermeasures against viral hepatitis B and C in Japan: An epidemiological point of view |
8 |
| Outbreak of hepatitis A linked to European outbreaks among men who have sex with men in Osaka, Japan, from March to July 2018 |
8 |
| Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society |
8 |
| Presence of varices in patients after hepatitis C virus eradication predicts deterioration in the FIB-4 index |
8 |
| Proposed diagnostic criteria for acute-on-chronic liver failure in Japan |
8 |
| Association between sarcopenia and osteoporosis in chronic liver disease |
8 |
| Epigenetic dysregulation in hepatocellular carcinoma: an up-to-date review |
8 |
| Meta-analysis of laparoscopic versus open liver resection for hepatocellular carcinoma |
8 |
| Hypozincemia is associated with human hepatocarcinogenesis in hepatitis C virus-related liver cirrhosis |
7 |
| Reduced handgrip strength is predictive of poor survival among patients with liver cirrhosis: A sex-stratified analysis |
7 |
| Intention-to-treat assessment of glecaprevir plus pibrentasvir combination therapy for patients with chronic hepatitis C in the real world |
7 |
| Analysis of 307 cases with drug-induced liver injury between 2010 and 2018 in Japan |
7 |
| Prompt initiation of high-dose i.v. corticosteroids seems to prevent progression to liver failure in patients with original acute severe autoimmune hepatitis |
7 |
| Microvascular invasion predicts a poor prognosis of solitary hepatocellular carcinoma up to 2 cm based on propensity score matching analysis |
7 |
| Dual-energy computed tomography for non-invasive staging of liver fibrosis: Accuracy of iodine density measurements from contrast-enhanced data |
7 |
| Clinicopathological investigation of steatohepatitic hepatocellular carcinoma: A multicenter study using immunohistochemical analysis of adenoma-related markers |
7 |
| Long non-coding RNA expression profile can predict early recurrence in hepatocellular carcinoma after curative resection |
7 |
